Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Newton

Showing results (931-940 of 1,058) with videos related to

Pageof 106
Sort By:
Stroke|June 15, 2019
Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell DiseaseEdward N Kija, Dawn E Saunders, Emmanuel Munubhi, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Scientific Reports|April 27, 2018
Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resourcesLiang-Chin Huang, Karen E Ross, Timothy R Baffi, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Molecular Cell|April 8, 2014
Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of AktPingping Wang, Zhihong Zhou, Anchang Hu, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science|May 7, 2025
A Hierarchical Model of the Symptom-Level Structure of Psychopathology in YouthMiriam K Forbes, Ashley L Watts, Maddison Twose, et al.
Epilepsia Open|March 29, 2018
Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross-sectional multisite studyFredrick Ibinda, Peter Odermatt, Symon M Kariuki, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerJordan S Fridman, Eian Caulder, Michael Hansbury, et al.
Pageof 106

Showing results (931-940 of 1,058) with videos related to

Sort By:
Pageof 106
Stroke|June 15, 2019
Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell DiseaseEdward N Kija, Dawn E Saunders, Emmanuel Munubhi, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Scientific Reports|April 27, 2018
Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resourcesLiang-Chin Huang, Karen E Ross, Timothy R Baffi, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Molecular Cell|April 8, 2014
Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of AktPingping Wang, Zhihong Zhou, Anchang Hu, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science|May 7, 2025
A Hierarchical Model of the Symptom-Level Structure of Psychopathology in YouthMiriam K Forbes, Ashley L Watts, Maddison Twose, et al.
Epilepsia Open|March 29, 2018
Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross-sectional multisite studyFredrick Ibinda, Peter Odermatt, Symon M Kariuki, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerJordan S Fridman, Eian Caulder, Michael Hansbury, et al.
Pageof 106